Advocacy Messages

The increase for the National Institutes of Health is a step in the right direction to accelerate medical progress but we cannot sustain our nation’s engine of discovery with dollops of fuel; a more robust investment is critical to maintaining our pre-eminence in science and saving lives.

Dear Research Advocate:

Dear Research Advocate:

By Margaret Foti, PhD, MD (h.c.), Chief Executive Officer, American Association for Cancer Research

Dear Research Advocate:

Letter to the editor by Research!America VP of Communications Suzanne Ffolkes published in The New York Times in response to article, ’€œLabs Are Told to Start Including a Neglected Variable: Females’€ (May 14, 2014)

Election season is all about voters getting to know the candidates running for public office in their state.  Through town hall and other meetings, articles and editorials, advertisements and debates, voters obtain information about each candidate that can inform their decision-making at the polls.

Dear Research Advocate:

Congress continues to pay particular attention to – and make decisions bearing on – the pace of medical progress. To briefly count the ways:

The Senate Labor-HHS Appropriations subcommittee heard testimony yesterday from agency heads within HHS about the significance of health-related spending, including spending on medical and health research. Read our written testimony here.

medprRemember that all day tomorrow, Tuesday May 6, is a social media Day of Action in conjunction with the Medical Progress NOW campaign.

Dear Research Advocate:

Pages

Subscribe to RSS - Advocacy Messages